Human iPSCs-based modeling unveils a dominant role of SETBP1 mutation in shaping stable chromatin accessibility landscape in GATA2 deficiency
RNA-seq (gene expression) · human · 25 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Myelodysplastic syndromesThis series is part of our curated briefing on it.
- Samples
- 25 samples: 11 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiencyNature communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE265824_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1104265 and SRA study SRP503865. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 11 replicated groups read from 25 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8229685 CTRL_biol_rep_1.2
- GSM8229686 CTRL_biol_rep_2.1 CTRL_biol_rep_2
- GSM8229687 CTRL_biol_rep_2.2 CTRL_biol_rep_2
- GSM8229688 GSA_biol_rep_1.1 GSA_biol_rep_1
- GSM8229689 GSA_biol_rep_1.2 GSA_biol_rep_1
- GSM8229690 GSA_biol_rep_2.1 GSA_biol_rep_2
- GSM8229691 GSA_biol_rep_2.2 GSA_biol_rep_2
- GSM8229692 GS_biol_rep_1.1 GS_biol_rep_1
- GSM8229693 GS_biol_rep_1.2 GS_biol_rep_1
- GSM8229694 G_biol_rep_1.1 G_biol_rep_1
- GSM8229695 G_biol_rep_1.2 G_biol_rep_1
- GSM8229696 G_biol_rep_2.1 G_biol_rep_2
- GSM8229697 G_biol_rep_2.2 G_biol_rep_2
- GSM9116220 CTRL_biol_rep_3 CTRL_biol
- GSM9116221 CTRL_biol_rep_4 CTRL_biol
- GSM9116222 GA_biol_rep_1 GA_biol
- GSM9116223 GA_biol_rep_2 GA_biol
- GSM9116224 GA_biol_rep_3 GA_biol
- GSM9116225 GA_biol_rep_4 GA_biol
- GSM9116226 GS_biol_rep_3 GS_biol
- GSM9116227 GS_biol_rep_4 GS_biol
- GSM9116228 A_biol_rep_1 A_biol
- GSM9116229 A_biol_rep_2 A_biol
- GSM9116230 S_biol_rep_1 S_biol
- GSM9116231 S_biol_rep_2 S_biol
- GSE248808 MED16 negatively regulates erythropoiesis and myelopoiesis through modulation of chromatin accessibility [RNA-Seq human] 16 samples same disease briefing · shares accessibility, chromatin
- GSE248810 MED16 negatively regulates erythropoiesis and myelopoiesis through modulation of chromatin accessibility [scRNA-Seq] 2 samples same disease briefing · shares accessibility, chromatin
- GSE291718 Analysis of chromatin accessibility relative to epigenetic features of azacitidine response in high-risk myelodysplastic syndrome 56 samples same disease briefing · shares accessibility, chromatin
- GSE248804 MED16 negatively regulates erythropoiesis and myelopoiesis through modulation of chromatin accessibility [ChIP-Seq human] 12 samples same disease briefing · shares accessibility, chromatin
- GSE248802 MED16 negatively regulates erythropoiesis and myelopoiesis through modulation of chromatin accessibility [ATAC-Seq human] 8 samples same disease briefing · shares accessibility, chromatin
- GSE298729 Chromatin accessibility of hematopoietic stem/progenitor cells (HSPCs) derived from MDS patients before and after disease progression 2 samples same disease briefing · shares accessibility, chromatin
- GSE282251 Multiclonal competition reveals impaired cell fitness of GATA2 deficient cells [ATAC-seq] 6 samples same disease briefing · shares gata2
- GSE248238 Modeling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCs [ChIP-seq] 37 samples same disease briefing · shares modeling
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.